ECMO in kids with cancer: a closer look at survival and risks

NCT ID NCT07712835

Completed Knowledge-focused Sponsor: Children's Mercy Hospital Kansas City Source: ClinicalTrials.gov ↗

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study examines how children under 18 with cancer or a history of a stem cell transplant do when they need a machine called ECMO to help them breathe. Researchers looked at bleeding, infections, and survival rates in children treated at one hospital, and compared survival with similar children who did not receive ECMO at another hospital. The goal is to better understand the risks and benefits of ECMO in this fragile group of patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: extracorporeal membrane oxygenation (ECMO)
What this could lead to: If successful, this study could help doctors better understand when ECMO might help children with cancer or a stem cell transplant who have severe breathing failure.
What could go wrong: This is a small, observational study, not a controlled trial. It cannot prove that ECMO improves outcomes, only describe what happened in these specific hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ECMO OUTCOMES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer hematopoietic and lymphoid cell neoplasm hematopoietic and lymphoid system neoplasm neoplasm respiratory failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ECMO OUTCOMES HEMATOPOETIC STEM CELL TRANSPLANT MALIGNANCIES, HEMATOLOGIC RESPIRATORY FAILURE (PEDIATRIC PATIENTS) SOLID TUMOR MALIGNANCIES

More trials for these conditions

Other studies related to the condition(s) this trial covers.